Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Toll Brothers Slips To Loss In Q1 - Quick Facts

RELATED NEWS
Trade TOL now with 

Toll Brothers Inc. (TOL: Quote) reported first-quarter net loss of $2.79 million, or $0.02 per share compared with last year's profit of $3.42 million, or $0.02 per share. The latest quarter results included a net tax benefit of $3.6 million, versus a net tax benefit of $20.5 million in fiscal 2011's first quarter, the company said.

On average, 19 analysts polled by Thomson Reuters expected earnings per share of $0.02 for the quarter. Analysts' estimates typically exclude one-time items.

On a pre-tax basis, quarterly loss reduced to $6.4 million from $17.0 million, while excluding inventory and joint venture write-downs, pre-tax income plunged to $1.7 million from $8.1 million a year ago.

Revenues totaled $321.95 million, lower than $334.12 million in the comparable period prior year, while 16 analysts estimated revenues of $360.84 million for the quarter.

Click here to receive FREE breaking news email alerts for Toll Brothers Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.